Organovo Holdings, Inc.
(NASDAQ : ONVO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.37%72.380.9%$622.00m
CELGCelgene Corporation
0.11%127.791.1%$445.82m
AMGNAmgen Inc.
0.33%167.841.1%$419.85m
BIIBBiogen Inc.
0.30%282.621.2%$357.46m
REGNRegeneron Pharmaceuticals, Inc.
0.59%470.732.7%$323.72m
VRTXVertex Pharmaceuticals Incorporated
0.68%149.131.9%$266.39m
ALXNAlexion Pharmaceuticals, Inc.
1.25%135.071.9%$220.70m
ILMNIllumina, Inc.
0.29%189.873.5%$216.98m
SRPTSarepta Therapeutics, Inc.
0.19%36.7719.8%$138.71m
INCYIncyte Corporation
-1.01%119.972.6%$129.63m
CLVSClovis Oncology, Inc.
0.14%72.0618.0%$129.38m
KITEKite Pharma, Inc.
1.75%132.4516.1%$123.97m
TSROTESARO, Inc.
0.44%114.3614.7%$122.22m
AAgilent Technologies, Inc.
0.46%61.531.5%$119.57m
BMRNBioMarin Pharmaceutical Inc.
0.30%81.164.4%$108.90m

Company Profile

Organovo Holdings, Inc. is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo Holdings was founded on January 30, 2012 and is headquartered in San Diego, CA.